649 related articles for article (PubMed ID: 25706066)
1. New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
Taskinen MR; Borén J
Atherosclerosis; 2015 Apr; 239(2):483-95. PubMed ID: 25706066
[TBL] [Abstract][Full Text] [Related]
2. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C
BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of Diabetic Dyslipidemia.
Hirano T
J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.
Toth PP
Vasc Health Risk Manag; 2016; 12():171-83. PubMed ID: 27226718
[TBL] [Abstract][Full Text] [Related]
6. Diabetic dyslipidemia: from evolving pathophysiological insight to emerging therapeutic targets.
Ng DS
Can J Diabetes; 2013 Oct; 37(5):319-26. PubMed ID: 24500559
[TBL] [Abstract][Full Text] [Related]
7. Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus.
Pandeya A; Sharma M; Regmi P; Basukala A; Lamsal M
Nepal Med Coll J; 2012 Dec; 14(4):278-82. PubMed ID: 24579534
[TBL] [Abstract][Full Text] [Related]
8. The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes.
Gonna H; Ray KK
Diabetes Obes Metab; 2019 Apr; 21 Suppl 1():6-16. PubMed ID: 31002453
[TBL] [Abstract][Full Text] [Related]
9. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
[TBL] [Abstract][Full Text] [Related]
10. Combination lipid therapy in type 2 diabetes mellitus.
Vergès B
Expert Opin Pharmacother; 2011 Jun; 12(9):1393-403. PubMed ID: 21323502
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of diabetic dyslipidaemia: where are we?
Vergès B
Diabetologia; 2015 May; 58(5):886-99. PubMed ID: 25725623
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol.
Xiao C; Dash S; Morgantini C; Hegele RA; Lewis GF
Diabetes; 2016 Jul; 65(7):1767-78. PubMed ID: 27329952
[TBL] [Abstract][Full Text] [Related]
13. Treatment of dyslipidemia in patients with type 2 diabetes.
Vijayaraghavan K
Lipids Health Dis; 2010 Dec; 9():144. PubMed ID: 21172030
[TBL] [Abstract][Full Text] [Related]
14. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
15. Clinical controversies in lipid management.
Tziomalos K
Panminerva Med; 2015 Jun; 57(2):65-70. PubMed ID: 25669164
[TBL] [Abstract][Full Text] [Related]
16. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
Quispe R; Martin SS; Jones SR
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
[TBL] [Abstract][Full Text] [Related]
17. Diabetic dyslipidemia.
Wu L; Parhofer KG
Metabolism; 2014 Dec; 63(12):1469-79. PubMed ID: 25242435
[TBL] [Abstract][Full Text] [Related]
18. Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register.
Eriksson M; Zethelius B; Eeg-Olofsson K; Nilsson PM; Gudbjörnsdottir S; Cederholm J; Eliasson B
Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):97-105. PubMed ID: 21354969
[TBL] [Abstract][Full Text] [Related]
19. Catabolism of lipoproteins and metabolic syndrome.
Therond P
Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):366-71. PubMed ID: 19474714
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride-rich lipoproteins and HDL: what do recent trials tell us?
Stock J
Atherosclerosis; 2013 Jun; 228(2):329-31. PubMed ID: 23623013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
